These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20032260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 3. Soluble guanylyl cyclase activation promotes angiogenesis.
    Pyriochou A, Beis D, Koika V, Potytarchou C, Papadimitriou E, Zhou Z, Papapetropoulos A.
    J Pharmacol Exp Ther; 2006 Nov; 319(2):663-71. PubMed ID: 16940434
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines.
    Haramis G, Zhou Z, Pyriochou A, Koutsilieris M, Roussos C, Papapetropoulos A.
    Br J Pharmacol; 2008 Nov; 155(6):804-13. PubMed ID: 18695639
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
    Antonova GN, Snead CM, Antonov AS, Dimitropoulou C, Venema RC, Catravas JD.
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A, Daou GB, Srivastava AK.
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [Abstract] [Full Text] [Related]

  • 10. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
    Pyriochou A, Vassilakopoulos T, Zhou Z, Papapetropoulos A.
    Life Sci; 2007 Nov 10; 81(21-22):1549-54. PubMed ID: 17945311
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation.
    Kajiya K, Huggenberger R, Drinnenberg I, Ma B, Detmar M.
    FASEB J; 2008 Feb 10; 22(2):530-7. PubMed ID: 17855621
    [Abstract] [Full Text] [Related]

  • 12. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B, Ni J, Vatish M, Singer DR.
    Microcirculation; 2008 Apr 10; 15(3):251-67. PubMed ID: 18386220
    [Abstract] [Full Text] [Related]

  • 13. PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis.
    Koika V, Zhou Z, Vasileiadis I, Roussos C, Finetti F, Monti M, Morbidelli L, Papapetropoulos A.
    Vascul Pharmacol; 2010 Apr 10; 53(5-6):215-22. PubMed ID: 20813203
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
    Murthy KS.
    J Pharmacol Exp Ther; 2008 Apr 10; 325(1):183-9. PubMed ID: 18180373
    [Abstract] [Full Text] [Related]

  • 15. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one inhibits neurite outgrowth and causes neurite retraction in PC12 cells independently of soluble guanylyl cyclase.
    Lee HG, Kim SY, Kim du S, Seo SR, Lee SI, Shin DM, De Smet P, Seo JT.
    J Neurosci Res; 2009 Jan 10; 87(1):269-77. PubMed ID: 18711750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
    Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T, Edes I, Koller A, Bagi Z.
    Am J Physiol Heart Circ Physiol; 2008 Jun 10; 294(6):H2558-64. PubMed ID: 18408126
    [Abstract] [Full Text] [Related]

  • 18. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
    Pyriochou A, Zhou Z, Koika V, Petrou C, Cordopatis P, Sessa WC, Papapetropoulos A.
    J Cell Physiol; 2007 Apr 10; 211(1):197-204. PubMed ID: 17226792
    [Abstract] [Full Text] [Related]

  • 19. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M, Kotsonis P, Siebe J, Clement B, Schmidt HH.
    Mol Pharmacol; 1999 Aug 10; 56(2):243-53. PubMed ID: 10419542
    [Abstract] [Full Text] [Related]

  • 20. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP.
    Br J Pharmacol; 2009 Jul 10; 157(5):781-95. PubMed ID: 19466990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.